A Study to Learn More About How Much of the Study Treatment Elinzanetant (or BAY3427080) Gets Absorbed, How Safe it is and How it Affects the Body in Healthy Female and Male Participants

Clinical trial NCT05351892 · COMPLETED

Trial details

NCT number: NCT05351892
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Hot Flashes Healthy Volunteers

Start date: 2022-05-04
Primary completion: 2022-06-09
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.